Unaudited Financial Results for the 2nd Quarter and Half Year ended 30.09.2026.

Vimta Labs Limited Vima Registered Office 142, IDA Phase II, Cherlapally Hyderabad-SOC 051 ,Telangana, India T: +914027264141 F +91 40 2726 3657 Driven by Quality. Inspired by Science. VLL\SE\049\2026-27 Date: 30.10.2026 BSE Limited, National Stock Exchange of India Limited, P J Towers, Dalal Street, "Exchange Plaza", Bandra, Kurla Complex, Mumbai 400001. Bandra (E), Mumbai -400051. Scrip Code: 524394 Trading Symbol: VIMTALABS Dear Six/Madam, Sub Outcome of the Board Meeting. Ref Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. With reference to the subject cited above, please find enclosed herewith unauclited Financial Results as per Regulation 33 of the SEBI (LODR) Regulations, 2015 for the 02 Quarter and Half Year ended 30 September 2026 along with Limited Review Report. The said Financial Results were duly reviewed and recommended by the Audit Committee and approved by the Board of Directors of the Company, at their respective meetings held today. Further to our earlier intimation dated 061 May 2026 regarding the proposed incorporation of a wholly owned subsidiary in the USA, we wish to inform you that the Board of Directors of the Company, at its meeting held today, took note of the incorporation of Vimta Labs LLC as a wholly owned subsidiary of the Company. The meeting of the Board of Directors of the Company commenced at 10:30 A.M. and concluded at 01:00 P.M. This is for your information and records. Thanking you, For VIMTA LABS LIMITED Sujani Vasireddi Company Secretary & Compliance Officer End: as above. Life Sciences Campus, # 5, Neovantage Science & Technology Park, Genome Valley, Shamirpet, Medchal-Malkajgiri District. Hyderabad -500101, Telangana, India. T : +91 4067404040 E: mdoffice@vimta.com URL : www.vimta.com CIN : L24110TG1990P1C011977 GATTAMANENI & Co. Flat No.404, HardhikAnmol, Road No.10, Kakateeya Hills, CHARTERED ACCOUNTANTS Madhapur Hyderabad 500081 Mobile "9849768009 E-mail gattamaneni_gs©yahoo.com Independent Auditor's Review Report on Unaudited Quarterly and year to date Financial Results under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 To the Board of Directors of VIMTA LABS LIMITED 1. We have reviewed the accompanying statement of unaudited financial results ('the Statement') of MIs VIMIA LABS LIMITED ('the Company'), for the quarter ended 30 September 2026 and the year to date results for the period 01 April 2026 to 30 September 2026, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) including relevant circulars issued by the SEBI from time to time. 2. This Statement, which is the responsibility of the Company's Management and approved by the Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, Interim Financial reporting ('Ind AS 34'), prescribed under Section 133 of the Companies Act, 2013 ('the Act'), and other accounting principles generally accepted in India. Our responsibility is to issue a report on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagement (SRE) 2410, Review of Interim Financial Information performed by the Independent Auditor of the Entity, issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with the Standards on Auditing specified under section 143(10) of the Act, and consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly we do not express an audit opinion. p.g.No: gsQ3S 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in Ind AS 34, prescribed under Section 133 of the Act, and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) including the manner in which it is to be disclosed, or that it contains any material misstatement. for GATTAMANENI & CO. Chartered Accountants (Firm Regn.No.009303S) Place: Hyderabad Date: 30-10-2026 K. HARIBABU Partner ICAl Ms. No. 222800 UDIN: 26222800CCNVZ51904 Vimta Labs Limited Vm * Registered Office 142, IDA Phase II, Cherlapally Hyderabad-500 051 ,Telangana, India T +91 40 2726 4141 F +91 40 2726 3657 Driven by Quality. Inspired by Science. Statement of Unaudited Financial Results for the Quarter and Half Year Ended September 30, 2026 (Amount in INR miLlions, except Earnings Per Share) - Quarter Ended Half Year Ended Year ended S. No. Particulars 30Sep26 30Jun26 30Sep25 30Sep26 30Sep25 31 Mar26 I Income from operations (a) Revenue from operations (Refer note no.5) 1,119.83 1,090.74 1,018.48 2,210.57 1,994.12 4,072.90 (b) Other income 29.04 38.12 26.58 67.16 44.07 89.89 Total Income 1,148.87 1,128.86 1,045.06 2,277.73 2,038.19 4,162.79 2 Expenses (a) Cost of materials consumed and testing expenditure 261.52 226.27 201.34 487.79 389.33 806.73 (b) Cost of lab setup (Refer note no.5) . 0.45 0.13 0.45 0.24 1.20 (c) Changes in inventories of work-in-progress . . . . . - (d) EmpLoyee benefits expense (Refer note no. 6) 306.67 294.20 286.13 600.87 564.31 1,144.06 (e) Finance costs 3.85 2.37 3.74 6.22 6.89 11.67 (I) Depreciation Amortisation expense 128.68 125.48 102.40 254.16 201.02 437.72 (g) Other expenses 172.90 196.71 188.58 369.61 361.05 705.72 Total Expenses 873.62 845.48 782.32 1,719.10 1,522.84 3,107.10 3 Profit/(Loss) before exceptional items and tax (1-2) 275.25 283.38 262.74 558.63 515.35 1,055.69 4 Exceptional Items Statutory Impact of new Labour Codes (Refer note no. 7) 16.16 - . - Profit/(Loss) before tax (3-4) 275.25 283.38 262,74 558.63 515.35 1,039.53 6 Tax expense (a) Current tax 67.53 58.14 66.71 125.67 134.45 262.37 (b) Taxes of earlier periods - 0.38 - 0.38 - 3.11 (c) Deferred tax (benefit)/expense 1.58 14.44 (3.17) 16.02 (7.23) (1.07) Total Tax Expense 69.11 72.96 63.54 142.07 127.22 264.41 7 Proflt/(Loss) for the perIod (5-6) 206.14 210.42 199.20 416.56 388.13 775.12 & Other Comprehensive Income/ (expense), net of tax expenses items that will not be reclassified subsequently to profit or loss: (a) Re-measurements of net defined benefit Liability (0.20) (0.20) (0.15) (0.40) (0.25) (0.78) (b) Income tax relating to the items 0.05 0.05 0.03 0.10 0.06 0.20 Total other comprehensive income/floss), net of tax (0.15) (0.15) (0.12) (0.30) (0.19) (0.58) 9 Total Comprehensive Income for the period (comprising Profit/(Loss) and 205.99 210.27 199.08 416.26 387.94 774.54 other Comprehensive income for the period (7+8] 10 Paid-up Equity Share Capital (Face value of Rs.21- per equity share) 89.40 89.34 89.08 89.40 89.08 89.34 11 Other Equity 4.47939 12 Eamings per equity share (EPS) (Face value of Rs.2 per share) (a) Basic (INR) 4.61 4.71 4.46 9.32 8.71 17.40 (b) Diluted (INR) 4.57 4.66 4.44 9.23 8.65 17.20 (EPS for the quarter ended are not annuaLised) 9303S FB.4° Life Sciences Campus, # 5, Neovantage Science & Technology Park, Genome Valley, Shamirpet, Medchal-Malkajgiri District. Hyderabad -500 101, Telangana, India. T: +91 4067404040 E: mdoffice@vimta.com URL www.vimta.com CIN : L24110T61990PLC011977 Notes to the results: 1. The above unaudited financial results for the quarter and half year ended September 30, 2026 have been reviewed and recommended by th [Showing first 8,000 characters — download PDF for full document]